By proceeding, you agree to our Terms of Use and Privacy Policy.
Jörg Bentzien. Research Fellow, Discovery. Alkermes, Inc.
Talks About #Fellow #
Preferred Locations #NorthAmerica
The 2-day programme addresses drug discovery in new modalities such as protein degradation, and case studies on the integration of screening approaches in phenotypic and genomics-based discovery, Organ-on-a-chip and 3D modelling.